Skip to main content

Articles

Page 32 of 34

  1. Cigarette smoke is associated with decreased female fertility, causing damage to ovarian function and disturbing follicle development. However, the effects of cigarette toxicants on ovarian function depend on ...

    Authors: Larissa LO Paixão, Rejane P Gaspar-Reis, Gabrielle PL Gonzalez, Aline S Santos, Aluana C Santana, Rachel MM Santos, Poli Mara Spritzer and Celly Cristina A Nascimento-Saba
    Citation: Journal of Ovarian Research 2012 5:25
  2. The global gene regulator Special AT-rich sequence-binding protein1 (SATB1) has been reported to reprogramme tumour cells into a more malignant phenotype and associate with poor clinical outcome in several can...

    Authors: Björn Nodin, Charlotta Hedner, Mathias Uhlén and Karin Jirström
    Citation: Journal of Ovarian Research 2012 5:24
  3. Anti-VEGF treatment has proven effective in recurrent ovarian cancer. However, the identification of the patients most likely to respond is still pending. It is well known that the angiogenesis is regulated by...

    Authors: Christine Vestergaard Madsen, Karina Dahl Steffensen, Dorte Aalund Olsen, Marianne Waldstrøm, Maja Smerdel, Parvin Adimi, Ivan Brandslund and Anders Jakobsen
    Citation: Journal of Ovarian Research 2012 5:23
  4. Autophagy is a lysosomal-driven catabolic process that contributes to preserve cell and tissue homeostases through the regular elimination of damaged, aged and redundant self-constituents. In normal cells, aut...

    Authors: Claudia Peracchio, Oscar Alabiso, Guido Valente and Ciro Isidoro
    Citation: Journal of Ovarian Research 2012 5:22
  5. Ovarian cancer is predominant of epithelial cell origin and often present at an advanced stage with poor prognosis. Most animal models of ovarian carcinoma yield thecal/granulose cell tumors, rather than adeno...

    Authors: Yiping Huang, Wei Jiang, Yisheng Wang, Yufang Zheng, Qing Cong and Congjian Xu
    Citation: Journal of Ovarian Research 2012 5:21
  6. The aim of this study was to assess the clinical value of preoperative blood levels of HE4 as a predictor of overall survival in patients with ovarian cancer and to validate previous data of HE4 and the ROMA a...

    Authors: Grigorios Kalapotharakos, Christine Asciutto, Emir Henic, Bertil Casslén and Christer Borgfeldt
    Citation: Journal of Ovarian Research 2012 5:20
  7. It is well known that somatotrophic/insulin signaling affects lifespan in experimental animals, and one of the signs of aging is progressive gonadal dysfunction.

    Authors: Sylwia Słuczanowska-Głąbowska, Maria Laszczyńska, Katarzyna Piotrowska, Wojciech Głąbowski, John J Kopchick, Andrzej Bartke, Magda Kucia and Mariusz Z Ratajczak
    Citation: Journal of Ovarian Research 2012 5:18
  8. The addition of bevacizumab to standard chemotherapy prolongs progression free survival in the first line treatment of epithelial ovarian cancer (EOC), but its cost/effectiveness is debated. We assessed the sa...

    Authors: Carlotta Defferrari, Sara Campora, Mauro D'Amico, Arnoldo Piccardo, Ennio Biscaldi, Daniela Rosselli, Ambra Pasa, Matteo Puntoni, Alberto Gozza, Alessandra Gennari, Silvia Zanardi, Rita Lionetto, Michela Bandelloni and Andrea DeCensi
    Citation: Journal of Ovarian Research 2012 5:17
  9. Differences in the incidences and types of DNA damage induced by antitumor agents for clear cell carcinoma (CCC) were determined in 2 ovarian CCC cell lines using γH2AX.

    Authors: Eriko Takatori, Tadahiro Shoji, Seisuke Kumagai, Takashi Sawai, Akira Kurose and Toru Sugiyama
    Citation: Journal of Ovarian Research 2012 5:16
  10. The polycystic ovary syndrome ( PCOS) affects approximately 6-10% of women of reproductive age and is characterized by chronic anovulation and hyperandrogenism. However, a comprehensive understanding of the mecha...

    Authors: Fang Wang, Bolan Yu, Wenjing Yang, Jianqiao Liu, Jiachun Lu and Xuefeng Xia
    Citation: Journal of Ovarian Research 2012 5:15
  11. Polycystic Ovary Syndrome (PCOS) is a multifactorial pathology that affects 10% of the women in reproductive age being the main cause of infertility due to menstrual dysfunction. Since 1980, it is known that P...

    Authors: Rosalbino Isabella and Emanuela Raffone
    Citation: Journal of Ovarian Research 2012 5:14

    The Expression of Concern to this article has been published in Journal of Ovarian Research 2018 11:98

    The Expression of Concern to this article has been published in Journal of Ovarian Research 2018 11:57

  12. New treatment strategies are emerging to target DNA damage response pathways in ovarian cancer. Our group has previously shown that the class I biased HDAC inhibitor romidepsin (FK228) induces DNA damage respo...

    Authors: Andrew J Wilson, Yi-Qiang Cheng and Dineo Khabele
    Citation: Journal of Ovarian Research 2012 5:12
  13. Serum CA125 is routinely used in the follow up of ovarian cancer. The objective of the present study was to evaluate the usefulness of CA125 in the detection of ovarian cancer recurrence.

    Authors: Elizabeth Varughese, Srinivas Kondalsamy-Chennakesavan and Andreas Obermair
    Citation: Journal of Ovarian Research 2012 5:11
  14. Struma ovarii is a rare form of ovarian neoplasm in a form of mature teratoma and is composed predominantly of thyroid tissue. In the literature review, there has only been 10 cases of this tumor, associated w...

    Authors: Nahid Mostaghel, Anahita Enzevaei, Khandan Zare and Masoome Fallahian
    Citation: Journal of Ovarian Research 2012 5:10
  15. Even though ovarian tumors are not generally considered estrogen-sensitive, estrogens may still have an impact on ovarian tumor progression. The recently identified trans-membrane estrogen receptor GPER is inv...

    Authors: Zuzana Kolkova, Vera Casslén, Emir Henic, Sara Ahmadi, Anna Ehinger, Karin Jirström and Bertil Casslén
    Citation: Journal of Ovarian Research 2012 5:9
  16. MicroRNAs (miRNAs) are a class of small non-coding RNAs which function in gene regulation with an important role in cell proliferation, maturation, and activity. The regulatory role of these small RNA molecule...

    Authors: Jason Baley and Julang Li
    Citation: Journal of Ovarian Research 2012 5:8
  17. A crucial step in the metastatic spread of ovarian cancer (OC) is the adhesion and implantation of tumor cells to the peritoneal mesothelium. In order to study this step in the cascade, we derived a pro-metast...

    Authors: Takafumi Watanabe, Toshihiro Hashimoto, Takashi Sugino, Shu Soeda, Hiroshi Nishiyama, Yutaka Morimura, Hidekazu Yamada, Steve Goodison and Keiya Fujimori
    Citation: Journal of Ovarian Research 2012 5:7
  18. The Dachshund homolog 2 (DACH2) gene has been implicated in development of the female genital tract in mouse models and premature ovarian failure syndrome, but to date, its expression in human normal and cancerou...

    Authors: Björn Nodin, Marie Fridberg, Mathias Uhlén and Karin Jirström
    Citation: Journal of Ovarian Research 2012 5:6
  19. Melatonin (N-acetyl-5-methoxytryptamine) is secreted during the dark hours at night by pineal gland, and it regulates a variety of important central and peripheral actions related to circadian rhythms and repr...

    Authors: Hiroshi Tamura, Akihisa Takasaki, Toshiaki Taketani, Manabu Tanabe, Fumie Kizuka, Lifa Lee, Isao Tamura, Ryo Maekawa, Hiromi Aasada, Yoshiaki Yamagata and Norihiro Sugino
    Citation: Journal of Ovarian Research 2012 5:5
  20. RNA-Seq allows a theoretically unbiased analysis of both genome-wide transcription levels and mutation status of a tumor. Using this technique we sought to identify novel candidate therapeutic targets expresse...

    Authors: Rebecca A Mosig, Li Lin, Emir Senturk, Hardik Shah, Fei Huang, Peter Schlosshauer, Samantha Cohen, Robert Fruscio, Sergio Marchini, Maurizio D'Incalci, Ravi Sachidanandam, Peter Dottino and John A Martignetti
    Citation: Journal of Ovarian Research 2012 5:4
  21. We sought to identify candidate serum biomarkers for the detection and surveillance of EOC. Based on RNA-Seq transcriptome analysis of patient-derived tumors, highly expressed secreted proteins were identified...

    Authors: Rebecca A Mosig, Mollie Lobl, Emir Senturk, Hardik Shah, Samantha Cohen, Eugene Chudin, Robert Fruscio, Sergio Marchini, Maurizio D'Incalci, Ravi Sachidanandam, Peter Dottino and John A Martignetti
    Citation: Journal of Ovarian Research 2012 5:3
  22. Malignant ovarian disease is characterised by high rates of mortality due to high rates of recurrent chemoresistant disease. Anecdotal evidence indicates this may be due to chemoresistant properties of cancer ...

    Authors: Michael F Gallagher, Cynthia CBB Heffron, Alexandros Laios, Sharon A O'Toole, Brendan Ffrench, Paul C Smyth, Richard J Flavin, Salah A Elbaruni, Cathy D Spillane, Cara M Martin, Orla M Sheils and John J O'Leary
    Citation: Journal of Ovarian Research 2012 5:2
  23. Some techniques of transvaginal ovarian drilling have been previously described. Nevertheless a monopolar transvaginal ovarian cauterization, that use the expertise and safety of transvaginal puncture for oocy...

    Authors: Anita M Pimentel, Danielle Kobayashi, Lucia M Kliemann, Renato Franjdlich, Edison Capp and Helena VE Corleta
    Citation: Journal of Ovarian Research 2012 5:1
  24. Resistance to current chemotherapeutic agents is a major cause of therapy failure in ovarian cancer patients, but the exact mechanisms leading to the development of drug resistance remain unclear.

    Authors: Cheryl A Sherman-Baust, Kevin G Becker, William H Wood III, Yongqing Zhang and Patrice J Morin
    Citation: Journal of Ovarian Research 2011 4:21
  25. Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of...

    Authors: Anna Felisiak-Golabek, Alina Rembiszewska, Iwona K Rzepecka, Lukasz Szafron, Radoslaw Madry, Magdalena Murawska, Tomasz Napiorkowski, Piotr Sobiczewski, Beata Osuch and Jolanta Kupryjanczyk
    Citation: Journal of Ovarian Research 2011 4:20
  26. Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of childbearing age, and it seems better to consider it as an ovarian manifestation of metabolic syndrome. The aim of the current stu...

    Authors: Afshin Mohammadi, Mohammadreza Aghasi, Leila Jodeiry-farshbaf, Shaker Salary-Lac and Mohammad Ghasemi-rad
    Citation: Journal of Ovarian Research 2011 4:19
  27. Glutathione peroxidase 3 (GPX3) is a selenocysteine-containing antioxidant enzyme that reacts with hydrogen peroxide and soluble fatty acid hydroperoxides, thereby helping to maintain redox balance within cell...

    Authors: Deep Agnani, Olga Camacho-Vanegas, Catalina Camacho, Shashi Lele, Kunle Odunsi, Samantha Cohen, Peter Dottino and John A Martignetti
    Citation: Journal of Ovarian Research 2011 4:18
  28. Ovarian cancer is the leading cause of death from gynecologic cancer in women worldwide. According to the National Cancer Institute, ovarian cancer has the highest mortality rate among all the reproductive can...

    Authors: Smriti Kumar, Arooshi Kumar, Parag P Shah, Shesh N Rai, Siva K Panguluri and Sham S Kakar
    Citation: Journal of Ovarian Research 2011 4:17
  29. The HOX genes are a family of homeodomain-containing transcription factors that determine cellular identity during development. Here we review a number of recent studies showing that HOX genes are strongly expres...

    Authors: Zoë L Kelly, Agnieszka Michael, Simon Butler-Manuel, Hardev S Pandha and Richard GL Morgan
    Citation: Journal of Ovarian Research 2011 4:16
  30. Adnexal cancers are in fifth place among the tumors with the highest mortality in the female population. The aim of the present study was to evaluate the accuracy of Multi-detector computed tomography (MDCT) o...

    Authors: Fatemeh Gatreh-Samani, Mohammad Kazem Tarzamni, Elaheh Olad-Sahebmadarek, Ali Dastranj and Aimaz Afrough
    Citation: Journal of Ovarian Research 2011 4:15
  31. Ovarian cancer is sixth most common cancer among women and the leading cause of death in women with gynecological malignancies. Despite the great impact ovarian cancer has on women's health and its great impac...

    Authors: Marcela F Paes, Renata D Daltoé, Klesia P Madeira, Lucas CD Rezende, Gabriela M Sirtoli, Alice L Herlinger, Leticia S Souza, Luciana B Coitinho, Débora Silva, Murilo F Cerri, Ana Cristina N Chiaradia, Alex A Carvalho, Ian V Silva and Leticia BA Rangel
    Citation: Journal of Ovarian Research 2011 4:14
  32. The presence of oocytes in the ovarian surface epithelium has already been confirmed in the fetal ovaries. We report the presence of SSEA-4, SOX-2, VASA and ZP2-positive primitive oocyte-like cells in the adul...

    Authors: Irma Virant-Klun, Thomas Skutella, Branko Cvjeticanin, Martin Stimpfel and Jasna Sinkovec
    Citation: Journal of Ovarian Research 2011 4:13
  33. Study of the hen immune system led to seminal contributions to basic immunological principles. Recent studies of spontaneous ovarian cancer in the laying hen show strikingly similar tumor types and antigen exp...

    Authors: Yi Yu, Seby L Edassery, Animesh Barua, Jacques S Abramowicz, Janice M Bahr, Ingegerd Hellstrom and Judith L Luborsky
    Citation: Journal of Ovarian Research 2011 4:12
  34. Endometriosis Health Profile (EHP-5) is a valid instrument to measure health-related quality of life in endometriosis. This study was conducted to culturally adapt and validate the EHP-5 in Iran.

    Authors: Azita Goshtasebi, Maryam Nematollahzadeh, Fatemeh Zahra Hariri and Ali Montazeri
    Citation: Journal of Ovarian Research 2011 4:11
  35. Epithelial ovarian cancer (EOC) is the leading cause of gynecologic cancer death in the USA. Recurrence rates are high after front-line therapy and most patients eventually die from platinum (Pt) - resistant d...

    Authors: Clarisse S Muenyi, Vanessa A States, Joshua H Masters, Teresa W Fan, C William Helm and J Christopher States
    Citation: Journal of Ovarian Research 2011 4:9
  36. Metformin, an oral biguanide traditionally used for the treatment of type 2 diabetes, is widely used for the management of polycystic ovary syndrome (PCOS)-related anovulation. Because of the significant preva...

    Authors: Mary E Sabatini, Lankai Guo, Maureen P Lynch, Joseph O Doyle, HoJoon Lee, Bo R Rueda and Aaron K Styer
    Citation: Journal of Ovarian Research 2011 4:8
  37. Recent evidence has suggested that the capability of cancer to grow, propagate and relapse after therapy is dependent on a small subset of the cell population within the tumor, called cancer stem cells. Theref...

    Authors: Moorthy P Ponnusamy, Parthasarathy Seshacharyulu, ArokiaPriyanka Vaz, Parama Dey and Surinder K Batra
    Citation: Journal of Ovarian Research 2011 4:7
  38. In the search for unique ovarian cancer biomarkers, ovarian specific cDNA microarray analysis identified hRad17, a cell cycle checkpoint protein, as over-expressed in ovarian cancer. The aim of this study was ...

    Authors: Jennifer L Young, E Colin Koon, Joseph Kwong, William R Welch, Michael G Muto, Ross S Berkowitz and Samuel C Mok
    Citation: Journal of Ovarian Research 2011 4:6
  39. Malignant transformation is a rare complication of mature cystic teratoma with squamous cell carcinoma being the most common type. We report a new case of squamous cell carcinoma in situ.

    Authors: Fatima A Zakkouri, Saloua Ouaouch, Saber Boutayeb, Mouna Rimani, Lamiae Gamra, Hind Mrabti and Hassan Errihani
    Citation: Journal of Ovarian Research 2011 4:5
  40. Sphingosine-1 receptor 1 (S1P1) plays a major role in regulating lymphocyte egress from peripheral lymph tissue. Lymphocyte trafficking is potentially a critical response to tumors and to tumor vaccines. Also,...

    Authors: Michael J Bradaric, Animesh Barua, Krishna Penumatsa, Yu Yi, Seby L Edassery, Sameer Sharma, Jacques S Abramowicz, Janice M Bahr and Judith L Luborsky
    Citation: Journal of Ovarian Research 2011 4:4
  41. The prostaglandin D2 (PGD2) pathway is involved in numerous biological processes and while it has been identified as a partner of the embryonic sex determining male cascade, the roles it plays in ovarian funct...

    Authors: Andalib Farhat, Pascal Philibert, Charles Sultan, Francis Poulat and Brigitte Boizet-Bonhoure
    Citation: Journal of Ovarian Research 2011 4:3
  42. Blood flow in the corpus luteum (CL) is closely related to luteal function. It is unclear how luteal blood flow is regulated. Standardized ovarian-stimulation protocol with a gonadotropin-releasing hormone ago...

    Authors: Akihisa Takasaki, Isao Tamura, Fumie Kizuka, Lifa Lee, Ryo Maekawa, Hiromi Asada, Toshiaki Taketani, Hiroshi Tamura, Katsunori Shimamura, Hitoshi Morioka and Norihiro Sugino
    Citation: Journal of Ovarian Research 2011 4:2
  43. We showed there are specific ALDH1 autoantibodies in ovarian autoimmune disease and ovarian cancer, suggesting a role for ALDH1 in ovarian pathology. However, there is little information on the ovarian express...

    Authors: Krishna Penumatsa, Seby L Edassery, Animesh Barua, Michael J Bradaric and Judith L Luborsky
    Citation: Journal of Ovarian Research 2010 3:28
  44. Ovarian cancer is the second most common cancer among women and the leading cause of death among gynecologic malignancies. In recent years, infrared (IR) spectroscopy has gained attention as a simple and inexp...

    Authors: Ranjana Mehrotra, Gunjan Tyagi, Deepak K Jangir, Ramesh Dawar and Noopur Gupta
    Citation: Journal of Ovarian Research 2010 3:27
  45. To verify the feasibility of ovarian stromal evaluation and correlate ovarian parameteres (echogenicity and volume) with hyperandrogenism, and both cardiovascular and metabolic risk factors in PCOS.

    Authors: Giuseppe Loverro, Giovanni De Pergola, Edoardo Di Naro, Massimo Tartagni, Cristina Lavopa and Anna Maria Caringella
    Citation: Journal of Ovarian Research 2010 3:25

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.